Cerity Partners LLC Fulgent Genetics, Inc. Transaction History

Cerity Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$47.98 - $62.75 $5,325 - $6,965	-111 Reduced 1.9%	5,723 $312,000
Q1 2022 Apr 25, 2022	SELL	$49.85 - $96.11 $10,119 - $19,510	-203 Reduced 3.36%	5,834 $364,000
Q4 2021 Feb 14, 2022	BUY	$77.3 - $105.0 $27,828 - $37,800	360 Added 6.34%	6,037 $607,000
Q3 2021 Oct 25, 2021	BUY	$74.87 - $110.87 $1,497 - $2,217	20 Added 0.35%	5,677 $511,000
Q2 2021 Aug 11, 2021	SELL	$66.8 - $100.45 $8,016 - $12,054	-120 Reduced 2.08%	5,657 $522,000
Q1 2021 Aug 11, 2021	SELL	$59.3 - $183.85 $8,124 - $25,187	-137 Reduced 2.32%	5,777 $558,000
Q1 2021 May 12, 2021	BUY	$59.3 - $183.85 $350,700 - $1.09 Million	5,914 New	5,914 $571,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Cerity Partners LLC with notifications on news.